These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 34793835)
41. Single channel properties of heterotetrameric mutant RyR1 ion channels linked to core myopathies. Xu L; Wang Y; Yamaguchi N; Pasek DA; Meissner G J Biol Chem; 2008 Mar; 283(10):6321-9. PubMed ID: 18171678 [TBL] [Abstract][Full Text] [Related]
42. A 37-amino acid sequence in the skeletal muscle ryanodine receptor interacts with the cytoplasmic loop between domains II and III in the skeletal muscle dihydropyridine receptor. Leong P; MacLennan DH J Biol Chem; 1998 Apr; 273(14):7791-4. PubMed ID: 9525869 [TBL] [Abstract][Full Text] [Related]
43. Immunophilins and coupled gating of ryanodine receptors. Lehnart SE; Huang F; Marx SO; Marks AR Curr Top Med Chem; 2003; 3(12):1383-91. PubMed ID: 12871170 [TBL] [Abstract][Full Text] [Related]
44. The cytoplasmic loops between domains II and III and domains III and IV in the skeletal muscle dihydropyridine receptor bind to a contiguous site in the skeletal muscle ryanodine receptor. Leong P; MacLennan DH J Biol Chem; 1998 Nov; 273(45):29958-64. PubMed ID: 9792715 [TBL] [Abstract][Full Text] [Related]
45. Two regions of the ryanodine receptor calcium channel are involved in Ca(2+)-dependent inactivation. Gomez AC; Yamaguchi N Biochemistry; 2014 Mar; 53(8):1373-9. PubMed ID: 24521037 [TBL] [Abstract][Full Text] [Related]
46. TRIC-A Channel Maintains Store Calcium Handling by Interacting With Type 2 Ryanodine Receptor in Cardiac Muscle. Zhou X; Park KH; Yamazaki D; Lin PH; Nishi M; Ma Z; Qiu L; Murayama T; Zou X; Takeshima H; Zhou J; Ma J Circ Res; 2020 Feb; 126(4):417-435. PubMed ID: 31805819 [TBL] [Abstract][Full Text] [Related]
47. Regulation of the RYR1 and RYR2 Ca2+ release channel isoforms by Ca2+-insensitive mutants of calmodulin. Fruen BR; Black DJ; Bloomquist RA; Bardy JM; Johnson JD; Louis CF; Balog EM Biochemistry; 2003 Mar; 42(9):2740-7. PubMed ID: 12614169 [TBL] [Abstract][Full Text] [Related]
48. Interaction of S100A1 with the Ca2+ release channel (ryanodine receptor) of skeletal muscle. Treves S; Scutari E; Robert M; Groh S; Ottolia M; Prestipino G; Ronjat M; Zorzato F Biochemistry; 1997 Sep; 36(38):11496-503. PubMed ID: 9298970 [TBL] [Abstract][Full Text] [Related]
49. Postulated role of interdomain interactions within the type 1 ryanodine receptor in the low gain of Ca2+-induced Ca2+ release activity of mammalian skeletal muscle sarcoplasmic reticulum. Murayama T; Oba T; Kobayashi S; Ikemoto N; Ogawa Y Am J Physiol Cell Physiol; 2005 Jun; 288(6):C1222-30. PubMed ID: 15677376 [TBL] [Abstract][Full Text] [Related]
50. Triadin binding to the C-terminal luminal loop of the ryanodine receptor is important for skeletal muscle excitation contraction coupling. Goonasekera SA; Beard NA; Groom L; Kimura T; Lyfenko AD; Rosenfeld A; Marty I; Dulhunty AF; Dirksen RT J Gen Physiol; 2007 Oct; 130(4):365-78. PubMed ID: 17846166 [TBL] [Abstract][Full Text] [Related]
51. IL-1α reversibly inhibits skeletal muscle ryanodine receptor. a novel mechanism for critical illness myopathy? Friedrich O; Yi B; Edwards JN; Reischl B; Wirth-Hücking A; Buttgereit A; Lang R; Weber C; Polyak F; Liu I; von Wegner F; Cully TR; Lee A; Most P; Völkers M Am J Respir Cell Mol Biol; 2014 Jun; 50(6):1096-106. PubMed ID: 24400695 [TBL] [Abstract][Full Text] [Related]
52. Ca(2+) sparks operated by membrane depolarization require isoform 3 ryanodine receptor channels in skeletal muscle. Pouvreau S; Royer L; Yi J; Brum G; Meissner G; Ríos E; Zhou J Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5235-40. PubMed ID: 17360329 [TBL] [Abstract][Full Text] [Related]
53. Intramolecular ex vivo Fluorescence Resonance Energy Transfer (FRET) of Dihydropyridine Receptor (DHPR) β1a Subunit Reveals Conformational Change Induced by RYR1 in Mouse Skeletal Myotubes. Bhattacharya D; Mehle A; Kamp TJ; Balijepalli RC PLoS One; 2015; 10(6):e0131399. PubMed ID: 26114725 [TBL] [Abstract][Full Text] [Related]
54. Divergent functional properties of ryanodine receptor types 1 and 3 expressed in a myogenic cell line. Fessenden JD; Wang Y; Moore RA; Chen SR; Allen PD; Pessah IN Biophys J; 2000 Nov; 79(5):2509-25. PubMed ID: 11053126 [TBL] [Abstract][Full Text] [Related]
57. A region of the ryanodine receptor critical for excitation-contraction coupling in skeletal muscle. Yamazawa T; Takeshima H; Shimuta M; Iino M J Biol Chem; 1997 Mar; 272(13):8161-4. PubMed ID: 9079632 [TBL] [Abstract][Full Text] [Related]
58. Dantrolene, a therapeutic agent for malignant hyperthermia, markedly improves the function of failing cardiomyocytes by stabilizing interdomain interactions within the ryanodine receptor. Kobayashi S; Yano M; Suetomi T; Ono M; Tateishi H; Mochizuki M; Xu X; Uchinoumi H; Okuda S; Yamamoto T; Koseki N; Kyushiki H; Ikemoto N; Matsuzaki M J Am Coll Cardiol; 2009 May; 53(21):1993-2005. PubMed ID: 19460614 [TBL] [Abstract][Full Text] [Related]
59. Calcitonin gene-related peptide restores disrupted excitation-contraction coupling in myotubes expressing central core disease mutations in RyR1. Vega AV; Ramos-Mondragón R; Calderón-Rivera A; Zarain-Herzberg A; Avila G J Physiol; 2011 Oct; 589(Pt 19):4649-69. PubMed ID: 21825032 [TBL] [Abstract][Full Text] [Related]
60. Ryanodine modification of RyR1 retrogradely affects L-type Ca(2+) channel gating in skeletal muscle. Bannister RA; Beam KG J Muscle Res Cell Motil; 2009; 30(5-6):217-23. PubMed ID: 19802526 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]